GUARDAMAGNA, Ornella
 Distribuzione geografica
Continente #
NA - Nord America 4.013
EU - Europa 3.523
AS - Asia 1.535
SA - Sud America 45
AF - Africa 35
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 9.178
Nazione #
US - Stati Uniti d'America 3.931
CN - Cina 951
IT - Italia 595
IE - Irlanda 470
SE - Svezia 467
DE - Germania 419
FR - Francia 356
UA - Ucraina 285
FI - Finlandia 267
KR - Corea 225
SG - Singapore 178
GB - Regno Unito 157
GR - Grecia 103
PL - Polonia 103
AT - Austria 99
RU - Federazione Russa 88
CA - Canada 62
VN - Vietnam 57
IN - India 30
BR - Brasile 27
BE - Belgio 23
TH - Thailandia 22
ES - Italia 21
MX - Messico 19
JP - Giappone 14
NL - Olanda 14
AU - Australia 13
ID - Indonesia 13
CH - Svizzera 11
CO - Colombia 11
EU - Europa 11
MU - Mauritius 9
IR - Iran 8
NO - Norvegia 7
RO - Romania 7
BG - Bulgaria 6
NG - Nigeria 6
TW - Taiwan 6
TR - Turchia 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
IL - Israele 4
PT - Portogallo 4
RS - Serbia 4
CM - Camerun 3
EG - Egitto 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SI - Slovenia 3
SN - Senegal 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BF - Burkina Faso 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
KE - Kenya 2
LV - Lettonia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
CI - Costa d'Avorio 1
CL - Cile 1
HK - Hong Kong 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TN - Tunisia 1
ZM - Zambia 1
Totale 9.178
Città #
Chandler 670
Beijing 628
Dublin 469
Houston 264
Villeurbanne 237
Princeton 197
Medford 188
Jacksonville 186
Ann Arbor 163
Ashburn 127
Fairfield 122
Wilmington 122
Singapore 111
Dearborn 93
Vienna 83
Warsaw 80
Torino 76
Woodbridge 75
Hefei 70
Milan 62
Nyköping 58
Fremont 55
Cambridge 54
Boardman 45
Guangzhou 40
West Jordan 40
Rome 38
Seattle 37
Nanchang 35
Boston 34
Verona 34
Dong Ket 30
Toronto 30
Falls Church 27
Redwood City 26
Kennett Square 25
Pisa 24
Nanjing 22
Brussels 20
Düsseldorf 20
Athens 19
Hebei 17
Lachine 17
Salt Lake City 17
Norwalk 16
Jinan 15
Santa Clara 15
Hangzhou 13
San Diego 12
Kunming 11
Avellino 10
Munich 10
Naples 10
San Mateo 10
Taizhou 10
Turin 9
Wuhan 8
Bengaluru 7
Chengdu 7
Graz 7
Pune 7
Shanghai 7
São Paulo 7
Toledo 7
Zhengzhou 7
Mariano Comense 6
Mountain View 6
Nanning 6
New York 6
Tokyo 6
Bari 5
Catanzaro 5
Chicago 5
Des Moines 5
Duncan 5
Jakarta 5
Medellín 5
Phoenix 5
Shenyang 5
Silver Spring 5
Southend 5
Trezzano Sul Naviglio 5
Veracruz 5
Washington 5
Baotou 4
Belfast 4
Bolzano 4
Borgaro Torinese 4
Bucharest 4
Changsha 4
Florianópolis 4
Latina 4
Milazzo 4
Moscow 4
Mumbai 4
Palermo 4
Philadelphia 4
Pravisdomini 4
Saviano 4
Taipei 4
Totale 5.156
Nome #
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 468
Alimentazione e prevenzione del rischio cardiovascolare 323
Serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia 229
Lysosomal acid lipase deficiency – An under-recognized cause of dyslipidaemia and liver dysfunction 221
Cardiovascular risk in children: apoB/apoA1 and non-HDL-cholesterol 175
A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia. 150
Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children 148
Effects of lycopene supplementation on oxidative stess in children affected by primary dyslipidemia. 124
Cholesteryl ester storage disese: experiences in pediatrics 120
Impact of nutrition since early life on cardiovascular prevention. 120
Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants 120
Diagnostic and clinical aspects of children affected by primary dyslipidemia. 115
Identification and management of dyslipidemic children 114
The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols 108
Correlation between intima media thickness measurement and biochemical markers of atherosclerosis in childhood 103
Usefulness of intima media thickness, ApoB and nonHDL-C in primary dislipidemic children. 99
Bifidobacteria supplementation: Effects on plasma lipid profiles in dyslipidemic children 97
The impact of familial hypobetalipoproteinemia in liver steatosis 93
HDL-C profile and BMI in dyslipidemic children. 92
A new mutation of apo av in severe hypertriglyceridemia 92
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene 90
L'alimentazione del bambino e la prevenzione del rischio cardiovascolare. 89
Diet in the treatment of familial combined hyperlipidemia in children 87
A new mutation of the apolipoprotein B gene originates the apo B32,4 truncated protein. 87
Il rischio cardiovascolare nel bambino affetto da dislipidemia primitiva. 86
Convulsive crisis in the young infant. Incidence of febrile convulsions in a an extensive case load over a period of years. 85
A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol 84
Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia 82
Apolipoprotein E allele frequencies in familial combined hyperlipidemia Italian families 82
ApoB AND NON-HDL-CHOLESTEROL: CARDIOVASCULAR RISK FACTORS IN CHILDREN 81
Natural History Study of Early Onset Lysosomal Acid Lipase (lal) Deficiency (wolman Disease) Confirms a Severe and Rapid Disease Course 79
Trattamento neonatale della malattia delle urine a sciroppo d'acero (MSUD) 78
Echographic evaluation of vascular damage in a cohort of dyslipemic children. 78
The treatment of hypercholesterolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanols 78
A novel loss of function mutation of PCSK9 gene in caucasians with low plasma LDL-cholesterol. 77
X-linked ectodermal dysplasia. Presentation of 2 cases. 76
Le dislipidemie in pediatria 75
Heterogeneity of the MELAS 3243 mutation 74
L'importanza della diagnosi del bambino affetto da dislipidemia primitiva 74
Lipoprotein(a) and Family History of Cardiovascular Disease in Children with Familial Dyslipidemias. 74
La prevenzione cardiovascolare nel bambino e nell’adolescente: Ruolo della colesterolemia. 74
The diagnosis of inherited dislipidenhas in children 73
Screening neonatale di massa per malattie metaboliche: 10 anni di attività nella regione Piemonte 72
Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease 72
The Treatment of Colesteryl Storage Disease (CESD) by Ezetimibe Monotherapy. 70
Bethanechol versus antiacids in the treatment of gastroesophageal reflux. 69
Clinical Features of Lysosomal Acid Lipase Deficiency 68
Impact of apo E genotype on familial combined hyperlipemia (FCHL) expression 67
EFFECTS OF LYCOPENE SUPPLEMENTATION ON OXIDATIVE STRESSS IN CHILDREN AFFECTED BY PRIMARY DYSLIPIDEMIA 67
Artery wall B-mode ultrasound measurment in hyperlipidemic children. 67
Catalytic activity of tetrahydrobiopterin in dihydropteridine reductase deficiency and indications for treatment. 66
Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption. 66
Inherited dyslipemias are disorders affecting children? 65
Familial hypobetalipoproteinemia and liver steatosis. 65
“Does apolipoprotein E (Apo E) epsilon 4 allele modulate the familial combined hyperlipidemia expression?” 65
Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk 65
Attempt of Indirect Screening of Tetrahydrobiopterin Deficiencies. 64
Prenatal diagnosis in primary hyperphenylalaninemias. 64
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 63
Familial combined hyperlipemia in childhood 62
The diagnosis of inherited dislipidemias in children. 62
Impaired lipid transport due to heterozygous hypobetalipoproteinemia. 62
Could dyslipidemic children benefit from glucomannan intake? 62
Antenatal Diagnosis of Tetrahydrobiopterin Deficiency by Quantification. 60
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 60
Serum levels of IgA and celiac disease. Case reports. 58
Proteine della soia: effetti metabolici e ruolo nella prevenzione cardiovascolare. 58
Influence of diet on lipoprotein profile in familial combined hyperlipidemia affected children 57
Il trattamento non farmacologico delle dislipidemie nel bambino 57
P-selectin levels in children affected by dyslipidemia. 57
Dihydropteridine reductase activity in fetal tissues 57
Per i bambini giusto nutrimento ed esercizio. Non troppo e non troppo poco 56
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 56
Familial Hypobetalipoproteinemia and liver steatosis. 56
Liver steatosis and familial hypobetalipoproteinemia due to new apolipoprotein B truncated proteins 55
Two mutations of Dihydropteridine Reductase Deficiency. 55
Evaluation of the intima-media thickness in familial combined hyperlipemia. 55
The clinical score for diagnosis of bronchiolitis in sucklings. Retrospective checking of 133 cases (1974-1981). 54
Prevenzione e screening delle dislipidemie primitive nel bambino: verso un nuovo approccio? 54
LDL receptor gene mutations and lipid pattern in Italian children affected by familial hypercholesterolemia 54
Selective screening of genetic dislipemias in Italian children. 54
Isolated Hyperlipoprotein(a) in children with familial cardiovascular events. 54
LDL Receptor gene mutation in italian children affected by familial hypercholesterolemia. 52
Identification of a MELAS patient presenting as intestinal occlusion 52
The inflammation biomarkers correlate with intima-media thickness in dyslipemic children. 51
Phytosterols Therapy in Children. 50
The familial hypercholesterolemia in Italian children. 50
Molecular Testing of Families with Ornithine Transcarbamylase (OTC) Deficiency 50
Placental barrier in mother-to-fetus transfer of tetrahydrobiopterin in humans 49
Fate of peripherally administered tetrahydrobiopterin in congenital tetrahydrobiopterin deficiency 49
Progression of 6-pyruvoyl-tetrahydropterin synthase deficiency from a peripheral into a central phenotype. 48
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 48
Prenatal-Diagnosis of Tetrahydrobiopterin Deficiency 48
Rapid detection of medium chain acyl-CoA dehydrogenase gene mutations by non-radioactive, single strand conformation polymorphism minigels. 47
A novel loss of function mutation of PCSK9 gene 47
Unusual case of atypic PKU: peripheral or central formo f PPH4S deficiency? 46
Recurrent episodes of bizarre behavior in a boy with ornithine transcarbamylase deficiency: diagnostic failure of protein loading and allopurinol challenge tests. 43
Genotype-phenotype correlations in ornithine-transcarbamylase deficiency. 43
Genotype/phenotype correlations in familial hypobetalipoproteinemia 43
Selective Screening of genetic dyslipidemias in italian children. 43
Totale 8.183
Categoria #
all - tutte 26.029
article - articoli 0
book - libri 0
conference - conferenze 10.233
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.299 0 0 54 121 60 254 112 64 96 88 418 32
2020/20211.134 148 85 59 54 124 55 148 60 151 71 68 111
2021/20221.277 23 22 28 98 66 27 78 82 58 121 324 350
2022/20231.966 255 132 65 168 203 488 164 128 218 29 69 47
2023/2024673 106 114 44 43 32 48 11 38 7 61 42 127
2024/202588 10 78 0 0 0 0 0 0 0 0 0 0
Totale 9.565